Skip to main content
. 2014 Nov 21;5:5383. doi: 10.1038/ncomms6383

Figure 9. NEAT1 is a strong prognosticator of prostate cancer.

Figure 9

(ad) Univariable forest plots comparing the expression of NEAT1’s short (NEAT1_1) and long isoform (NEAT1_2) to clinicopathologic variables in the pooled Mayo cohort (n=594) (a) BCR, (b) MET, (c) PCSM and (d) GS>7. Pathological tumour stage 3 or greater (pT3+), lymph node invasion (LNI), surgical margin status (SMS) positive, seminal vesicle invasion (SVI), extra capsular extension (ECE), preoperative PSA (pPSA), adjuvant hormone therapy and adjuvant radiation therapy are shown.